Peyronie's disease as a complication of chronic graft versus host disease

Hematology

Volumn 7, Issue 3, 2002, Pages 165-168

  Grigg, A P ^a   Underhill, C ^b   Russell, J ^b   Sale, G ^c  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b University of Washington ^*

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Chronic GVHD; Peyronie's disease

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HYDROXYUREA; METHOTREXATE; PREDNISOLONE;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CHRONIC DISEASE; CONTROLLED STUDY; ERECTILE DYSFUNCTION; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MYELODYSPLASIA; PEYRONIE DISEASE; PHIMOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; SCLERODERMA; SKIN DISCOLORATION; TARGET ORGAN; THROMBOCYTOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; WHOLE BODY RADIATION; ADOLESCENT; IMMUNOSUPPRESSIVE TREATMENT; METHODOLOGY; MYELODYSPLASTIC SYNDROME; PATHOLOGY;

ADOLESCENT; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSION; MALE; MYELODYSPLASTIC SYNDROMES; PENILE INDURATION;

EID: 0036401553     PISSN: 10245332     EISSN: None     Source Type: Journal    
DOI: 10.1080/1024533021000008182     Document Type: Article

References (13)

1. Vogelsang, G.B. (2001) "How I treat chronic graft-versus-host disease", Blood 97, 1196-1201.
2. Corson, S.L., Sullivan, K., Batzer, F., August, C., Storb, R. and Donnall Thomas, E. (1982) "Gynecologic manifestations of chronic graft-versus-host disease", Obstet. Gynecol. 60, 488-492.
3. Kami, M., Kanda, Y., Sasaki, M., Takeda, N., Tanaka, Y., Saito, T., Ogawa, S., Honda, H., Chiba, S., Mitani, K., Hirai, H. and Yazaki, Y. (1998) "Phimosis as a manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation", Bone Marrow Transplant. 21, 721-723.
4. McRoberts, W. (1969) "Peyronie's disease", Surg. Gynecol. Obstet., 1291-1294.
5. Tefekli, A., Kandirali, E., Erol, H., Alp, T., Koksal, T. and Kadioglu, A. (2001) "Peyronie's disease in men under age 40: characteristics and outcome", Int. J. Impotence Res. 13, 18-23.
6. Enzinger, F.M. and Weiss, S.W. (1995) "Fibromatoses", In: Enzinger, F.M. and Swiss, S.W., eds, Soft tissue tumors, Ed. 3 (Mosby-Year Book, St Louis).
7. Hinman, Jr, F. (1980) "Etiologic factors in Peyronie disease", Urol. Int. 35, 407-4132.
8. Rompel, R., Weidner, W. and Mueller-Eckhardt, G. (1991) "HLA association of idiopathic Peyronie's disease: an indication of autoimmune phenomena in etiopathogenesis?", Tissue Antigens 38, 104-106.
9. Chilton, C.P., Castle, W.M., Westwood, C.A. and Prior, J.P. (1982) "Factors associated in the aetiology of Peyronie's disease", Br. J. Urol. 54, 748-750.
10. Hellstrom, W. and Bivalacqua, T. (2000) "Peyronie's disease: etiology, medical, and surgical therapy", J. Androl. 21, 347-354.
11. Gualdieri, L., Valentini, G., Lupoli, S. and Giordano, M. (1988) "Peyronie's disease in systemic sclerosis: report of two cases (letter)", J. Rheumatol. 15, 380-388.
12. Gelbard, M., Dorey, F. and James, K. (1990) "The natural history of Peyronie's disease", J. Urol. 144, 1376-1379.
13. Lischer, G.H. and Nehra, A. (2001) "New advances in Peyronie's disease", Curr. Opin. Urol. 11, 631-636.